KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Cash from Operations (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Cash from Operations readings, the most recent being 1192000000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations rose 64.87% to 1192000000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 8287000000.0, a 1.82% increase, with the full-year FY2025 number at 7818000000.0, down 9.8% from a year prior.
  • Cash from Operations hit 1192000000.0 in Q1 2026 for Thermo Fisher Scientific, down from 3457000000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 3723000000.0 in Q4 2023 to a low of 723000000.0 in Q1 2025.
  • Median Cash from Operations over the past 5 years was 1960000000.0 (2024), compared with a mean of 2072764705.88.
  • Biggest five-year swings in Cash from Operations: crashed 66.89% in 2023 and later surged 71.6% in 2024.
  • Thermo Fisher Scientific's Cash from Operations stood at 3487000000.0 in 2022, then grew by 6.77% to 3723000000.0 in 2023, then dropped by 11.63% to 3290000000.0 in 2024, then grew by 5.08% to 3457000000.0 in 2025, then tumbled by 65.52% to 1192000000.0 in 2026.
  • The last three reported values for Cash from Operations were 1192000000.0 (Q1 2026), 3457000000.0 (Q4 2025), and 2239000000.0 (Q3 2025) per Business Quant data.